Company news
Avicanna Inc news in 2020
Avicanna Inc's news releases, calls and decks from 2020, newest first.
Avicanna Announces Closing of Public Offering of Units
December 8, 2020
Avicanna Announces Pricing of Public Marketed Offering of Units
November 13, 2020
Avicanna Announces Overnight Marketed Public Offering of Units
November 12, 2020
Avicanna Reports Third Quarter 2020 Financial Results and Provides Corporate Update
November 12, 2020
Avicanna Announces Closing of Non-Brokered Convertible Debenture Financing
November 2, 2020
Avicanna Announces Results of Annual General and Special Meeting
October 20, 2020
Growth Company Investor Presentations Now Available for On-Demand Viewing
October 12, 2020
Live Growth Opportunities Investor Conference October 8th
October 5, 2020
Avicanna Enters Agreement to Develop and License Cannabinoid Tablet Formulations for US Distributor Partner
September 29, 2020
Avicanna's RHO Phyto(TM) Rapid Act Sprays are Now Available Nation Wide in Canada Through Medical Cannabis by Shoppers(TM)
September 21, 2020
Avicanna's subsidiary obtains GPP certification and authorization by INVIMA for the compounding and sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia
September 14, 2020
Avicanna Advances its Supply Chain Business and Announces Filing of Amended Interim Financial Statements
September 4, 2020
Avicanna Advances its Supply Chain Business with Commercial Exports of CBG And CBD into the United States and Germany as well as Industrial Scale THC Quota Granted by the Colombian Authorities
August 24, 2020
Avicanna Closes Non-Brokered Private Placement Raising $2.7 Million
August 18, 2020
Avicanna Reports Second Quarter 2020 Financial Results and Provides Corporate Update
August 17, 2020
Avicanna's RHO Phyto(TM) Medical Product Line is Now Available Nation-Wide in Canada Through Medical Cannabis by Shoppers Inc.(TM)
August 12, 2020
Avicanna and Red White & Bloom Enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States
August 11, 2020
Avicanna Inc. to Host Second Quarter 2020 Investor Conference Call
August 7, 2020
Avicanna announces the award of two Canadian government NSERC grants: 1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph
July 24, 2020
Avicanna Announces Participation in a Medical Cannabis Real-World Evidence (MC-RWE) Research Study Led by the University Health Network in Partnership with Medical Cannabis by Shoppers(TM) using its Rho Phyto(TM) Advanced Medical Cannabis Formulary of Products
July 15, 2020
Cannabis & CBD Biopharma Investor Presentations Now Available for On-Demand Viewing
July 10, 2020
Live Investor Conference & Webinar: Cannabis & CBD Biopharma Industry Companies Present July 9th
July 7, 2020
Avicanna Announces Co-development of a Cannabinoid-based Formulation for Treatment of COVID-19 related Lung Inflammation with Support from the Mitacs Accelerate Program
June 23, 2020
Avicanna to Host Virtual Symposium Titled "Medical Cannabis 2.0" on July 21st, 2020 in Partnership with Medical Cannabis By Shoppers(TM) in Anticipation of the Launch of its Rho Phyto(TM) Product Line
June 22, 2020
Avicanna Completes First Ever Export of Feminized Hemp Seeds For Cultivation Use to the United States and Closes the Initial Sale
June 18, 2020
Avicanna Successfully Registers the First Group of its Pura Earth(TM) CBD-Based Derma-Cosmetic Product Line in the European Union in Preparation for its Commercialization
June 9, 2020
Avicanna Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 24, 2020
Avicanna to Postpone Reporting First Quarter 2020 Results Due to Delays Caused by COVID-19
May 14, 2020
Avicanna Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with World-Class Canadian Manufacturer MediPharm Labs
May 14, 2020
Avicanna Receives Government Support and Approval for First Ever Export of Hemp Seeds From Colombia
May 7, 2020
Avicanna Closes Non-Brokered Private Placement with Group of Strategic Investors and Announces Warrant Re-Pricing
April 21, 2020
Avicanna Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update
April 15, 2020
Avicanna to Postpone Reporting Fourth Quarter and Full Year 2019 Results Due to Delays Caused by COVID-19
March 30, 2020
Avicanna to Supply Australian Market with Cannabis-Based Medicinal Products Through Distribution Agreement with Cannvalate
February 24, 2020
Avicanna Ranks Highest Amongst Global Cannabis Companies in the SAM Corporate Sustainability Assessment (CSA)
February 6, 2020
Avicanna Closes First Tranche of Private Placement
January 24, 2020
Avicanna Announces Appointment of Benjamin Leavenworth as Independent Director
January 21, 2020
Avicanna Announces the Successful Completion of its Clinical Study Evaluating the Effect of an Emollient Cream Containing 0.5% Cannabidiol on Skin Hydration
January 13, 2020
Avicanna Announces Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc., to Distribute Avicanna's Advanced and Evidence-based Medical Cannabis and Derma-Cosmetic Products Across Canada
January 10, 2020